Propel Bio Management, LLC Kempharm, Inc Put Options Transaction History
Propel Bio Management, LLC
- $101 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KMPH
# of Institutions
112Shares Held
29.9MCall Options Held
418KPut Options Held
43K-
Woodline Partners LP San Francisco, CA4.14MShares$20.4 Million0.15% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.65MShares$18 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.82MShares$14 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.7MShares$13.3 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.34MShares$11.6 Million0.58% of portfolio
About KEMPHARM, INC
- Ticker KMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,493,600
- Market Cap $170M
- Description
- KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...